Adam S. Mostafa
2021
In 2021, Adam S. Mostafa earned a total compensation of $1.3M as Chief Financial Officer and Treasurer at X4 Pharmaceuticals, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,220 |
|---|---|
| Salary | $430,193 |
| Stock Awards | $723,518 |
| Total | $1,338,931 |
Mostafa received $723.5K in stock awards, accounting for 54% of the total pay in 2021.
Mostafa also received $185.2K in non-equity incentive plan and $430.2K in salary.
Rankings
In 2021, Adam S. Mostafa's compensation ranked 7,707th out of 12,406 executives tracked by ExecPay. In other words, Mostafa earned more than 37.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,707 out of 12,406 | 38th |
Division Manufacturing | 3,397 out of 5,492 | 38th |
Major group Chemicals And Allied Products | 1,506 out of 2,368 | 36th |
Industry group Drugs | 1,340 out of 2,089 | 36th |
Industry Biological Products, Except Diagnostic Substances | 307 out of 452 | 32nd |
Source: SEC filing on April 25, 2022.
Mostafa's colleagues
We found two more compensation records of executives who worked with Adam S. Mostafa at X4 Pharmaceuticals in 2021.
News
X4 Pharmaceuticals CEO Paula Ragan's 2022 pay jumps 81% to $3.9M
April 25, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021
X4 Pharmaceuticals CEO Paula Ragan's 2019 pay jumps 171% to $2.5M
April 28, 2020
X4 Pharmaceuticals CEO René BCPS' 2018 pay jumps 188% to $3.4M
May 22, 2019